Muthukumaran N, Ma S, Reddi A H
Bone Cell Biology Section, National Institute of Dental Research, Bethesda, MD 20892.
Coll Relat Res. 1988 Sep;8(5):433-41. doi: 10.1016/s0174-173x(88)80016-5.
Subcutaneous implantation of demineralized collagenous bone matrix results in local induction of new bone formation. The dose dependence of bone induction was investigated using different amounts of rat demineralized bone matrix (DBM) and also osteogenin-enriched fraction with and without inactive collagenous bone matrix (ICBM). There is a threshold for bone induction; at least 10 mg of DBM is required. There is a dose dependent increase in bone induction between 10 to 25 mg. Exogenous type I collagen was found to be stimulatory to bone induction when suboptimal doses of DBM are employed. The activity of osteogenin-enriched dissociative extract was enhanced by addition of ICBM. These results imply that optimal bone induction requires the combined action of soluble osteogenin-enriched fraction and insoluble collagenous substratum.
脱矿质胶原骨基质的皮下植入可导致局部诱导新骨形成。使用不同量的大鼠脱矿质骨基质(DBM)以及添加和不添加无活性胶原骨基质(ICBM)的富含骨生成素的组分研究了骨诱导的剂量依赖性。骨诱导存在一个阈值;至少需要10毫克DBM。在10至25毫克之间骨诱导呈剂量依赖性增加。当使用次优剂量的DBM时,发现外源性I型胶原对骨诱导有刺激作用。添加ICBM可增强富含骨生成素的解离提取物的活性。这些结果表明,最佳骨诱导需要可溶性富含骨生成素的组分和不溶性胶原基质的联合作用。